Freemantle N - Search Results

1

Clinical outcomes in high-hypoglycaemia-risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first-generation basal insulin analogue in the United States : Results from the DELIVER High Risk real-world study.

Sullivan SD, Freemantle N, Gupta RA, Wu J, Nicholls CJ, Westerbacka J, Bailey TS. Sullivan SD, et al. Among authors: freemantle n. Endocrinol Diabetes Metab. 2022 Jan;5(1):e00306. doi: 10.1002/edm2.306. Epub 2021 Nov 22. Endocrinol Diabetes Metab. 2022. PMID: 34807513 Free PMC article.

2

Patient-led versus physician-led titration of insulin glargine in patients with uncontrolled type 2 diabetes: a randomized multinational ATLAS study.

Garg SK, Admane K, Freemantle N, Odawara M, Pan CY, Misra A, Jarek-Martynowa IR, Abbas-Raza S, Mirasol RC, Perfetti R. Garg SK, et al. Among authors: freemantle n. Endocr Pract. 2015 Feb;21(2):143-57. doi: 10.4158/EP14079.OR. Endocr Pract. 2015. PMID: 25297660 Clinical Trial.

3

Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis.

Freemantle N, Chou E, Frois C, Zhuo D, Lehmacher W, Vlajnic A, Wang H, Chung HW, Zhang Q, Wu E, Gerrits C. Freemantle N, et al. BMJ Open. 2016 Feb 15;6(2):e009421. doi: 10.1136/bmjopen-2015-009421. BMJ Open. 2016. PMID: 26880669 Free PMC article. Review.

4

Clinical correlates of hypoglycaemia over 4 years in people with type 2 diabetes starting insulin: An analysis from the CREDIT study.

Home P, Calvi-Gries F, Blonde L, Pilorget V, Berlingieri J, Freemantle N. Home P, et al. Among authors: freemantle n. Diabetes Obes Metab. 2018 Apr;20(4):921-929. doi: 10.1111/dom.13179. Epub 2018 Jan 7. Diabetes Obes Metab. 2018. PMID: 29205734 Free PMC article.

5

Comment on "a comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin-naïve patients with type 2 diabetes".

Freemantle N, Jourdan S. Freemantle N, et al. Diabetes Obes Metab. 2019 Jul;21(7):1758-1759. doi: 10.1111/dom.13711. Epub 2019 Apr 11. Diabetes Obes Metab. 2019. PMID: 30900796 Free PMC article. No abstract available.

6

Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus.

Freemantle N, Mauricio D, Giaccari A, Bailey T, Roussel R, Franco D, Berthou B, Pilorget V, Westerbacka J, Bosnyak Z, Bonnemaire M, Cali AMG, Nguyên-Pascal ML, Penfornis A, Perez-Maraver M, Seufert J, Sullivan SD, Wilding J, Wysham C, Davies M. Freemantle N, et al. Curr Med Res Opin. 2020 Apr;36(4):571-581. doi: 10.1080/03007995.2019.1708287. Epub 2020 Jan 19. Curr Med Res Opin. 2020. PMID: 31865758 Free article. Clinical Trial.

7

Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes: protocol of REALI project.

Freemantle N, Bonadonna RC, Gourdy P, Mauricio D, Mueller-Wieland D, Bigot G, Ciocca A, Mauquoi C, Rollot M, Bonnemaire M. Freemantle N, et al. BMJ Open. 2020 Apr 28;10(4):e033659. doi: 10.1136/bmjopen-2019-033659. BMJ Open. 2020. PMID: 32350009 Free PMC article.

8

Insulin glargine 300 units/mL for the treatment of individuals with type 2 diabetes in the real world: A review of the DELIVER programme.

Blonde L, Bailey T, Sullivan SD, Freemantle N. Blonde L, et al. Among authors: freemantle n. Diabetes Obes Metab. 2021 Aug;23(8):1713-1721. doi: 10.1111/dom.14405. Epub 2021 Jun 1. Diabetes Obes Metab. 2021. PMID: 33881797 Free PMC article. Review.

9

iGlarLixi (insulin glargine 100 U/ml plus lixisenatide) is effective and well tolerated in people with uncontrolled type 2 diabetes regardless of age: A REALI pooled analysis of prospective real-world data.

Guja C, Kis JT, Haluzík M, Bonnemaire M, Bigot G, Tournay M, Freemantle N, Seufert J. Guja C, et al. Among authors: freemantle n. Diabetes Obes Metab. 2023 Jun;25(6):1723-1730. doi: 10.1111/dom.15027. Epub 2023 Mar 21. Diabetes Obes Metab. 2023. PMID: 36810874

10

Factors associated with weight gain in people with type 2 diabetes starting on insulin.

Balkau B, Home PD, Vincent M, Marre M, Freemantle N. Balkau B, et al. Among authors: freemantle n. Diabetes Care. 2014 Aug;37(8):2108-13. doi: 10.2337/dc13-3010. Epub 2014 May 13. Diabetes Care. 2014. PMID: 24824546 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

578 results

Search Page